EN FR

news

17/07/2017

HRA Pharma appoints Martyn Hilton as Global Commercial Director
26/06/2017

Restricted access to emergency contraception in Poland is a backwards step for women’s reproductive health rights
12/06/2017

Ulipristal acetate for Emergency Contraception to be included on the Essential Medicines List by the World Health Organization
03/04/2017

HRA Pharma appoints David Wright as Chief Executive Officer
14/03/2017

HRA Pharma Strengthens Board with Experienced Industry Experts

Media

filter by theme

< 1 2 3 4 5 6 7 8 9 10 11 >

September 2009

HRA Pharma Named Finalist for the 2009 Scrip Awards and the 2009 Clinical Research Excellence Awards.

September 2009

HRA Pharma Reinforces Operational Presence in Europe with Italian Subsid

July 2009

HRA Pharma Marks Next Step in European Expansion with UK Subsidiary.

June 2009

NorLevo®, HRA Pharma's Emergency Contraceptive Pill, Now Available in Canada.

May 2009

HRA Pharma Granted European Marketing Authorization for ellaOne®.

May 2009

HRA Pharma and Preglem Announce Successful Completion of Phase IIB for Ulipristal Acetate for the Treatment of Uterine Fibroids.

April 2009

HRA Pharma Appoints Erin Gainer as CEO to Lead Company Through Next Phases of International Growth.